https://charts.traderzeitung.de/phases/US4884452065 string(1462) "{"isin":"US4884452065","name":"Zevra Therapeutics Inc","stock_id_xnas":22560614,"stock_id_xnys":null,"generated_at":"2026-08-09 08:01:00","days":[{"date":"2026-08-05","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":10.535,"close_at":"2026-08-05 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":10.5,"close_at":"2026-08-06 00:15:00","complete":true,"perf_pct":-0.3322}]},{"date":"2026-08-06","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":11.33,"close_at":"2026-08-06 15:26:00","complete":true,"perf_pct":7.9048},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":11.87,"close_at":"2026-08-06 21:59:00","complete":true,"perf_pct":4.7661},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":11.56,"close_at":"2026-08-07 21:59:00","complete":true,"perf_pct":-2.6116},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":11.16,"close_at":"2026-08-07 22:39:00","complete":true,"perf_pct":-3.4602}]}]}"

KemPharm Aktie News & Nachrichten

[WKN: A2QLX7 | Symbol: KMPH]

Realtimekurs

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

10J

Alles

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über KemPharm gefunden werden.

KemPharm Nachrichtenticker öffnen

MT Newswires 24.07.2026 14:16 Uhr

Zevra Therapeutics' Arimoclomol erhält negatives Votum von EU-Regulierungsbehörde; Aktien fallen

08:15 AM EDT, 24.07.2026 (MT Newswires) -- Die Aktien von Zevra Therapeutics (ZVRA) fielen am Freitagmorgen vorbörslich um 31%, nachdem das Unternehme